Contracting Officer, Code 074, Naval Hospital, Boone Road, Bremerton, WA 98312-1898

65 -- RADIOPHARMACEUTICAL STANDING ORDER SOL N68095-00-Q-1010 DUE 092199 POC Becky Smith, Purchasing Agent, 360-475-4462 E-MAIL: Becky Smith, Purchasing Agent, smithre@pnw.med.navy.mil. The Naval Hospital, Bremerton WA requires a STANDING/DELIVERY ORDER FOR RADIOPHARMACEUTICALS. Contract period is from 10-1-99 to 9-30-2000, With two (2) option years. Required items are as follows: (ESTIMATED) Schillings Dicipac -- 5EA/YR; Gallium-67 Citrate -- 30EA/YR; Tc99m Sestamibi -- 268EA/YR Tc99m Mebrofenin -- 40EA/YR; Tc99m MAA -- 20EA/YR; Tc99m DTPA AEROSOL -- 20EA/YR; Tc99m Mertinatide -- 32EA/YR; Tc99m MDP -- 425EA/YR; Tc99m ALBUMIN COLLOID -- 27ea/yr; tC99M Glucoheptate 1EA/YR; Tc99m DMSA -- 1EA/YR; 99mTc04 Multidose (50mCi) -- 365EA/YR; Tc99mHMPAO-WBC -- 7 EA/YR; Indinum 111 WBC -- 11EA/YR; NAI Therapy Capsule (15mCi) -- 5EA/YR; I-123 100uCi Capsule -- 21EA/YR; I-123 200uCi Capsule -- 21EA/YR; TI-201 (1mCi) -- 20EA/YR. DELIVERY AND RESPONSE REQUIREMENTS: 1) Delivery of routine Radiopharmaceuticals orders will be delivered no later than 0730 on required date. 2) Emergency orders placed duringnormal working hours will be delivered within 1 hour of order placement. 3) After normal working hours/weekends all emergency orders placed will be delivered within 2 hours of order placement. 4)Products delivered that do not meet delivery schedule requirements will be billed at 50% of contract rate. 5) WBC labeling must be completed and returned to Naval Hospital with 5 hours of taking custody of the patient's whole blood. RADIOPHARMACEUTICAL REQUIREMENTS: 1) Radio-Purity testing will be performed on all (exception- WBC labeling) products delivered to Naval Hospital. All products must meet the Kit Manufacturer's minimum Radio-Purity requirements. 2) No product substitutions will be allowed without prior approval of a nuclear medicine technologist. 3) TC MAA doses will not exceed the product insert maximum suggested number of particles. In cases when the pharmacy is notified that the dose is for a patient with Pulmonary Hypertension or a right shunt no more that 100,000 particles will be provided. 4) All diagnostic Radiopharmaceuticals must be within +-10% of the dose calibrated for the estimated time of use. 5) All I-131 NAI Therapeutical capsules must be within +-5% of the dose requested. These products will be calibrated for the estimated time of use. 6) M099 breakthrough concentration will never exceed 0.15 uCi/mCi c99m. 7) Aluminum levels will always be 10ugm/ml. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Far 52.212-1 Instructions to Offerors -- Commercial; Far 52.212-2 Evaluation -- Commercial Items; Far 52.212-3 Offeror Representation and CertificationsCommercial Ietms; Far 52.212-4 Contract Terms and Conditons -- Commercial items; Far 52.212-5 Contract Tems and Conditions required to implement Statutes of excutive orders Commercial Items. Award is to be made under Simplified Acquisition Procedures. All responsible sources may submit a quotation be fax to 360-475-4355***** Posted 09/11/99 (W-SN379198). (0254)

Loren Data Corp. http://www.ld.com (SYN# 0287 19990915\65-0004.SOL)